Some of the George Clinical DARE-19 team were able to get together at the Citeline Award dinner as a finalist for Research Team of the Year.
Citeline, a comprehensive global R&D intelligence firm providing insights into the global clinical trial landscape and the development of clinical trial programs, selected the DARE-19 team of George Clinical based on their compelling international accomplishments during the height of the COVID-19 pandemic.
This award recognizes the clinical research teams who have made significant contributions in advancing a new therapy through one or more clinical phases. Mikhail Kosiborod, a member of George Clinical’s scientific leadership, was the principal investigator of DARE-19, an international Phase III trial in 1,250 patients evaluating the efficacy and safety of a medication and local standard of care therapy in adults hospitalized with COVID-19.
Learn more - https://bit.ly/DARETeam
#ScienceServiceSolutions #ImprovingHealthWorldwide #NooneLeftBehind #ClinicalTrials #COVID19